In August 2023, a 27-year-old Malaysian woman was diagnosed with ovarian cancer. Despite undergoing traditional treatment, her condition swiftly worsened, and by February 2024, the cancer had recurred with peritoneal involvement. Her health deteriorated rapidly, leading to significant weight loss, reliance on tube feeding, and prolonged hospitalization due to unstable conditions. Even with chemotherapy, her tumor marker levels soared from 40,000 to 110,000. Additionally, her liver and overall body function declined, forcing her oncologist to halt chemotherapy. With limited options remaining for such aggressive ovarian cancer with peritoneal metastasis, she chose to start ECCT while still hospitalized.
2023年8月，一位27岁的马来西亚女性被诊断患有卵巢癌。尽管接受了传统治疗，她的病情迅速恶化，到2024年2月，癌症已复发并伴有腹膜转移。她的健康状况急剧恶化，体重显著下降，需依赖鼻饲管进食，并因病情不稳定而长期住院。即便接受化疗，她的肿瘤标志物水平仍从40,000上升到110,000。此外，她的肝功能和整体身体状况也在恶化，迫使她的肿瘤医生不得不中止化疗。在没有太多选择的情况下，她决定在住院期间开始接受ECCT治疗。The results observed over a 16-day period are remarkable and demonstrate significant improvements in both liver function and tumor markers. She was able to resume chemotherapy and continue her fight against cancer.
在仅仅16天的治疗期间，她的血液检测结果显示出显著的改善，表明她的肝功能和肿瘤标志物都有了显著改善。她因此得以继续接受化疗，继续与癌症抗争。Liver Function Improvement:
Initial blood test results showed elevated liver function markers, indicating stress and damage:
- ALT: 40
- ALP: 267
- GGT: 195
After 16 days of treatment with ECCT alongside chemotherapy, the markers improved dramatically:
- ALT: 20
- ALP: 157
- GGT: 88
肝功能改善： 最初的血液检测结果显示，她的肝功能标志物水平升高，表明肝脏受到了压力和损害：
ALT：40
ALP：267
GGT：195经过16天的ECCT联合化疗治疗后，这些标志物显著改善：
ALT：20
ALP：157
GGT：88Tumor Marker Improvement:
The initial tumor markers were notably high, reflecting the aggressive nature of the cancer:
- Ca 19.9: 117128.4
- CEA: 4.9
- Ca 15.3: 76.4
- Ca 125: 272.8
Following the 16-day treatment period, significant reductions in these markers were observed:
- Ca 19.9: 77763.4
- CEA: 4.2
- Ca 15.3: 68.5
- Ca 125: 166.3
肿瘤标志物改善： 最初的肿瘤标志物水平异常高，反映了癌症的侵袭性：
Ca 19.9：117128.4
CEA：4.9
Ca 15.3：76.4
Ca 125：272.8经过16天的治疗后，这些标志物显著下降：
Ca 19.9：77763.4
CEA：4.2
Ca 15.3：68.5
Ca 125：166.3This combination therapy has not only shown clinical success but also provided hope and a better quality of life for her. She hope by sharing this that ECCT's innovative approach in integrating with systemic treatments presents a promising path for cancer patients seeking effective solutions like her.
这种组合疗法不仅显示出临床上的成功，还为她提供了希望和更好的生活质量。ECCT结合系统治疗的创新方法为寻求有效解决方案的癌症患者提供了一个充满希望的前景。
Comments